Germing, U <br/><br/>
Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).  [electronic resource] 

 -  Leukemia  Dec 2005 
 - 2223-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2403963  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Clinical Enzyme Tests<br/>Female<br/>Humans<br/>L-Lactate Dehydrogenase--blood<br/>Male<br/>Middle Aged<br/>Models, Theoretical<br/>Multivariate Analysis<br/>Myelodysplastic Syndromes--classification<br/>Prognosis<br/>Retrospective Studies<br/>Risk Assessment<br/>Survival Rate